Aviso Financial’s ResMed RMD Stock Holding History

Aviso Financial’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$40.9M	Sell	209,744 -1,767	-0.8%	-$366K	1.42%	28
2026 Q1	$47.5M	Buy	211,511 +8,466	+4%	+$2.11M	1.69%	25
2025 Q4	$48.9M	Buy	203,045 +1,663	+0.8%	+$425K	1.86%	23
2025 Q3	$55.1M	Buy	201,382 +3,017	+2%	+$824K	2.24%	17
2025 Q2	$51.2M	Buy	198,365 +9,147	+5%	+$2.18M	2.31%	15
2025 Q1	$42.4M	Buy	189,218 +4,630	+3%	+$1.08M	2.09%	17
2024 Q4	$42.2M	Buy	184,588 +5,310	+3%	+$1.28M	2.13%	17
2024 Q3	$43.8M	Buy	179,278 +3,781	+2%	+$845K	2.17%	17
2024 Q2	$33.7M	Buy	+175,497	New	+$35.6M	1.88%	19

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Aviso Financial's RMD Position: Q2 2026 in Review

Aviso Financial reduced its ResMed (RMD) stake by 0.84% in Q2 2026, selling an estimated $366K and leaving 209,744 shares worth $40.9M. The position accounts for 1.42% of the portfolio, ranked #28.

Aviso Financial first reported a position in RMD in Q2 2024 and has held it in 9 quarters since. The position peaked at $55.1M in Q3 2025. 889 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Aviso Financial held 209,744 shares of ResMed worth $40.9M as of Q2 2026.
Aviso Financial sold 1,767 ResMed shares in Q2 2026, an estimated $366K.
ResMed made up 1.42% of Aviso Financial's portfolio in Q2 2026, its #28 holding.
Aviso Financial first reported a position in ResMed in Q2 2024 and has held it in 9 quarters since.
Aviso Financial's ResMed position peaked at $55.1M in Q3 2025.
889 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Aviso Financial's 13F filing for Q2 2026, filed 13 Aug 2026.